EP1: Putting back the patient-physician relationship at the center, with Prof. C. Michael Gibson

What will the future of cardiology and emergency medicine look like, in the era of digital health and artificial intelligence? In this episode, featuring Prof. C. Michael Gibson from Harvard Medical School, we look at some of the latest technological achievements, and what it will take for health systems to realize their true potential at scale. This comes with its own set of challenges, related to implementation, adoption, and culture, where a shift in healthcare needs to operate globally. However, it also nurtures a vision where patients and physicians are placed back at the heart of the matter, fostering trust, communication, and care delivery that is more personalized than ever before. Dr. C. Michael Gibson is Professor of Medicine at Harvard Medical School, Chief Executive Officer of the non-profit Baim Institute for Clinical Research and the Academic Research Organization PERFUSE, serving as well as Interventional Cardiologist at Beth Israel Deaconess Medical Center. As the inventor of several coronary blood flow measures widely used today in clinical practice, he has led numerous large-scale clinical trials, and his research has been published in more than 700 peer-reviewed publications. Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?su... Get in touch with us: https://www.roche.com/   / roche     / roche     / roche     / roche   Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. For more information and insights visit: https://www.roche.com/